Brian McNamara has been appointed Chief Executive Officer of GSK’s Consumer Healthcare division. He has succeeded Emma Walmsley who was last month appointed GSK CEO Designate succeeding Sir Andrew Witty as GSK CEO.
In his new role, McNamara will report to Andrew Witty until Walmsley becomes CEO. He has join GSK’s Corporate Executive Team and will continue as a member of the Board of the Consumer Healthcare Joint Venture with Novartis. The group added that he will be based in the UK.
McNamara was previously Head of Europe & Americas at GSK Consumer Healthcare. He joined GSK from Novartis following completion of GSK’s three-part transaction with Novartis and has been a member of GSK’s Consumer Healthcare Executive Team since 2015.
Prior to joining GSK, he spent eleven years at Novartis and sixteen years at Procter & Gamble.
Sir Andrew Witty, GSK CEO, said: “With his significant experience and expertise, Brian is the clear choice to build on the current momentum we are seeing in our business and fully maximise the future opportunities we have with our brands and to deliver the benefits of the integration.”